| |
Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
The regulatory authorities require biosafety testing of biologics and biopharmaceuticals for mycoplasma, bacterial and fungal contamination.
|
All assays are performed in accordance with Good Laboratory Practice (GLP).
|
 |
|
|
